Table 2.
Variant analysis* in COVID-19 patients with or without H/O vaccination.
| No of vaccine doses (No of recipients) | Wild (Wuhan) | kappa | Delta | Alpha |
|---|---|---|---|---|
| One dose (84) | 2 (2.3%) | 26 (30.9%) | 56 (66.6%) | 0 |
| 2 doses (42) | 0 | 13 (30.95%) | 29 (69.05%) | 0 |
| None (168) | 4 (2.38%) | 41 (24.4%) | 117 (69.65%) | 1(0.59%) |
Six (3 each in 1 and 2 doses recipients) sequences exhibited V382L mutation while 3 among the non-vaccinated group exhibited N440K mutation.